Can Generic Intravenous Levetiracetam Be Used for Acute Repetitive Convulsive Seizure or Status Epilepticus? A Randomized Controlled Trial

INTRODUCTION: Intravenous levetiracetam (IV LEV) is approved for treatment status epilepticus (SE). However, the drug’s high cost must be considered when deciding on a treatment strategy. This study aimed to compare the efficacy of brand-name and generic IV LEV for acute repetitive convulsive seizur...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neurol Ther
Päätekijät: Wongjirattikarn, Rachot, Sawanyawisuth, Kittisak, Pranboon, Sineenard, Tiamkao, Siriporn, Tiamkao, Somsak
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer Healthcare 2019
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6858918/
https://ncbi.nlm.nih.gov/pubmed/31407191
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40120-019-00150-x
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia